CUTANEOUS T-CELL LYMPHOMA STAGE II

This adverse event was reported 22 times

These drugs are most commonly taken by patients reporting CUTANEOUS T-CELL LYMPHOMA STAGE II:

# Drug Count
0 DUPILUMAB 8
1 METHOTREXATE SODIUM 8
2 METHOTREXATE 7
3 MYCOPHENOLATE MOFETIL 5
4 ADALIMUMAB 3
5 ADALIMUMAB-AATY 3
6 ADALIMUMAB-ADAZ 3
7 ADALIMUMAB-FKJP 3
8 GABAPENTIN 3
9 IXEKIZUMAB 3
See all common drugs associated with CUTANEOUS T-CELL LYMPHOMA STAGE II

CUTANEOUS T-CELL LYMPHOMA STAGE II is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BEXAROTENE 2 0.0015
1 ROMIDEPSIN 1 0.0006
2 MECHLORETHAMINE HYDROCHLORIDE 1 0.0004
3 ACITRETIN 2 0.0004
4 DASPONE 2 0.0002
5 DAPSONE GEL, 5% 2 0.0002
6 DAPSONE 2 0.0002
7 FLUOCINONIDE TOPICAL SOLUTION USP, 0.05% 1 0.0002
8 BRENTUXIMAB VEDOTIN 1 0.0001
9 CLOBETASOL PROPIONATE OINTMENT USP, 0.05% 1 0.0001
See all drugs enriched for association with CUTANEOUS T-CELL LYMPHOMA STAGE II